Tag: pharmaceutical drugs

CRISPR Trials to Watch in 2018

CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.

Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis

Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global innovator specializing in the development of pharmaceutical and...

Isodiol International Inc. Increases Size of Non-Brokered Offering and Retains Clarus Securities as Financial Advisor

Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical,...

Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis

Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global innovator specializing in the development of pharmaceutical and...

Isodiol International Inc. Announces Binding Agreement to Acquire 51% of Farmtiva and Commence Hemp Farming in California

Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical...

Isodiol International Inc. Completes Acquisition of KURE™ Corp

Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical...

Isodiol Receives Government Approval for Pure, Natural CBD as an Active Pharmaceutical Ingredient

Isodiol International LLC (CSE:ISOL, OTC:LAGBF, FSE:LBGA.F), a global CBD innovator specializing in the development of pharmaceutical actives and health and...